Matthew Lowe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matthew Lowe has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
- Ranald Iain Mackay
Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
5 shared publications - Amy L. Chadwick
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
3 shared publications - David J. Thomson
Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
3 shared publications - Francesca Albertini
Center for Proton Therapy, Paul Scherrer Institute PSI, Forschungsstrasse 111, Villigen, 5232, SWITZERLAND
3 shared publications - Karen Joy Kirkby
Division of Cancer Sciences, The University of Manchester, 3rd Floor Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Oak Road, Manchester, M20 3DA, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
3 shared publications - Marcel van Herk
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
3 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 15TR01
A systematic review on the clinical implementation of 4D particle therapy
Intrafractional motion in the thoracic and abdominal regions remains a major challenge in particle therapy representing one of the key anatomical changes during radiotherapy. Interfractional changes further contribute to cumulative uncertainties and may require adaptive strategies over the course of treatment. The high dose conformality and steep dose fall-off of particle beams, combined with motion-induced range variations, make dose delivery highly sensitive to temporal and anatomical changes. This systematic review provides an overview of clinically implemented 4D treatment approaches addressing intrafractional motion for thoracic and abdominal indications, aiming to support harmonisation of clinical practices across centres and vendors. Systematic searches in PubMed and Web of Science identified relevant publications from January 2020 to December 2025 covering the full 4D workflow in particle therapy. The focus was on clinical implementation for lung, pancreas, liver, lymphoma, oesophagus, and breast, complemented by phantom studies and ongoing research activities. Publications were screened by eight experts using predefined inclusion and exclusion criteria. Writing and synthesis were conducted by a multidisciplinary panel of eighteen experts. A total of 751 publications were identified, of which 231 were included and categorised into six key subtopics: motion management, imaging, treatment planning optimisation and evaluation, clinical indications, phantom studies, and future perspectives. The results confirm that intrafractional motion remains a major source of uncertainty across the workflow. Despite numerous proposed 4D techniques, clinical implementation varies widely. A key limitation is the lack of standardised methods for 4D dose evaluation and interplay assessment, particularly relevant for hypofractionated treatments and advanced delivery techniques. Increasing clinical experience demonstrates that motion-related challenges can be effectively managed using appropriate 4D-aware workflows. This review represents an important step towards establishing consensus and developing guidelines for treating moving targets in particle therapy.
- 6 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 15TR01
Open AccessA systematic review on the clinical implementation of 4D particle therapy
Intrafractional motion in the thoracic and abdominal regions remains a major challenge in particle therapy representing one of the key anatomical changes during radiotherapy. Interfractional changes further contribute to cumulative uncertainties and may require adaptive strategies over the course of treatment. The high dose conformality and steep dose fall-off of particle beams, combined with motion-induced range variations, make dose delivery highly sensitive to temporal and anatomical changes. This systematic review provides an overview of clinically implemented 4D treatment approaches addressing intrafractional motion for thoracic and abdominal indications, aiming to support harmonisation of clinical practices across centres and vendors. Systematic searches in PubMed and Web of Science identified relevant publications from January 2020 to December 2025 covering the full 4D workflow in particle therapy. The focus was on clinical implementation for lung, pancreas, liver, lymphoma, oesophagus, and breast, complemented by phantom studies and ongoing research activities. Publications were screened by eight experts using predefined inclusion and exclusion criteria. Writing and synthesis were conducted by a multidisciplinary panel of eighteen experts. A total of 751 publications were identified, of which 231 were included and categorised into six key subtopics: motion management, imaging, treatment planning optimisation and evaluation, clinical indications, phantom studies, and future perspectives. The results confirm that intrafractional motion remains a major source of uncertainty across the workflow. Despite numerous proposed 4D techniques, clinical implementation varies widely. A key limitation is the lack of standardised methods for 4D dose evaluation and interplay assessment, particularly relevant for hypofractionated treatments and advanced delivery techniques. Increasing clinical experience demonstrates that motion-related challenges can be effectively managed using appropriate 4D-aware workflows. This review represents an important step towards establishing consensus and developing guidelines for treating moving targets in particle therapy.
- Open Access
- 2 July 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (14) , 145003
Improving Plan Quality in Adaptive Proton Therapy Using an Interactive Dose Modification Tool.
Anatomical changes during proton therapy (PT) often necessitate plan adaptation. In online adaptation, re-optimizing using the original planning constraints has been proposed to speed-up the optimization time. However, the re-optimized plan may not reach the original plan quality. For this, an interactive dose modification (IDM) tool offers a promising approach, whereby fluences of proton pencil beams can be locally varied via interactive dose manipulations. We assessed the feasibility of using the IDM tool to improve the daily optimized plan, in cases where some clinical objectives are unmet. Approach: The IDM tool enables users to click on the dose distribution to locally increase/decrease dose, and underlying pencil beam weights, with immediate visual feedback. Four cases, treated with PT and exhibiting anatomical changes, were retrospectively studied in a simulated adaptive workflow (16 daily images were used). For each case, we compared three plans: a) re-calculated (but not re-optimized) on daily anatomy without adaptation, b) a plan re-optimized using the original planning constraints, c) a plan re-optimized as in b) but followed by modification using the IDM tool. We evaluated clinical endpoint fulfillment, dose deviations to clinical goals, and required modification time. Main results: Overall, plan a) resulted in 40 clinical endpoints being unmet that were fulfilled in the original plan, with deviations up to 9.4 Gy(RBE); plan b) resulted in 34 such endpoints, with deviations ≤2.5 Gy(RBE); and plan c) reduced these to 3 and deviations to ≤0.5 Gy(RBE). Target coverage (D98%,D95%) remained within 4 Gy(RBE) of the original plan for plan a) and 2.5 Gy(RBE) for b) and c). Average time for IDM was 2 minutes (30s-6 minutes). Significance: The IDM tool enables efficient improvement of plan quality in adaptive PT. Its speed, intuitiveness and effectiveness in restoring clinical goals supports its potential integration into routine online adaptive workflows.
- 2 July 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (14) , 145003
Open AccessImproving Plan Quality in Adaptive Proton Therapy Using an Interactive Dose Modification Tool.
Anatomical changes during proton therapy (PT) often necessitate plan adaptation. In online adaptation, re-optimizing using the original planning constraints has been proposed to speed-up the optimization time. However, the re-optimized plan may not reach the original plan quality. For this, an interactive dose modification (IDM) tool offers a promising approach, whereby fluences of proton pencil beams can be locally varied via interactive dose manipulations. We assessed the feasibility of using the IDM tool to improve the daily optimized plan, in cases where some clinical objectives are unmet. Approach: The IDM tool enables users to click on the dose distribution to locally increase/decrease dose, and underlying pencil beam weights, with immediate visual feedback. Four cases, treated with PT and exhibiting anatomical changes, were retrospectively studied in a simulated adaptive workflow (16 daily images were used). For each case, we compared three plans: a) re-calculated (but not re-optimized) on daily anatomy without adaptation, b) a plan re-optimized using the original planning constraints, c) a plan re-optimized as in b) but followed by modification using the IDM tool. We evaluated clinical endpoint fulfillment, dose deviations to clinical goals, and required modification time. Main results: Overall, plan a) resulted in 40 clinical endpoints being unmet that were fulfilled in the original plan, with deviations up to 9.4 Gy(RBE); plan b) resulted in 34 such endpoints, with deviations ≤2.5 Gy(RBE); and plan c) reduced these to 3 and deviations to ≤0.5 Gy(RBE). Target coverage (D98%,D95%) remained within 4 Gy(RBE) of the original plan for plan a) and 2.5 Gy(RBE) for b) and c). Average time for IDM was 2 minutes (30s-6 minutes). Significance: The IDM tool enables efficient improvement of plan quality in adaptive PT. Its speed, intuitiveness and effectiveness in restoring clinical goals supports its potential integration into routine online adaptive workflows.
- Open Access
- 23 May 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Proton pencil beam scanning lattice radiotherapy: technical implementation and comparison against photon-based delivery
Objectives: Spatially fractionated radiotherapy in the form of a lattice of high-dose regions within the tumor has potential to improve the therapeutic response compared to standard radiotherapy. We aimed (1) to develop and dosimetrically validate a proton pencil-beam scanning lattice radiotherapy (LRT) planning technique, (2) to compare against a photon VMAT LRT technique, and (3) to assess which clinical sites are feasible for treatment. Methods: 10 cases were selected, covering sites in the brain, neck, pelvis, abdomen and shoulder with gross tumor volumes greater than 100 cm3. LRT plans were developed for a Varian ProBeam system, aiming to deliver 20 Gy to the lattice vertices while minimizing dose to surrounding tissues. Plan-specific quality assurance (PSQA) was performed by independent Monte-Carlo calculation and physical dosimetric verification. End-to-end tests were performed using a CIRS head phantom containing EBT4 film. Plan quality was evaluated against VMAT LRT. Results: Clinically acceptable proton LRT plans were produced, delivering 16-20 Gy to the lattice vertices, a mean PTV dose of 2 Gy and satisfying organ-at-risk dose constraints. PSQA and end-to-end tests met clinical tolerances for non-LRT plans. For large target volumes, proton LRT produced lattices with a greater number of vertices than VMAT LRT. Conclusions: Proton LRT is technically viable using currently available delivery systems. Large tumors such as sarcoma are the most likely candidates for future clinical studies, but proton LRT is feasible for target volumes as small as 100 cm3. Advances in knowledge: The study demonstrates the feasibility of proton LRT for early phase clinical trials.
- 23 May 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Open AccessProton pencil beam scanning lattice radiotherapy: technical implementation and comparison against photon-based delivery
Objectives: Spatially fractionated radiotherapy in the form of a lattice of high-dose regions within the tumor has potential to improve the therapeutic response compared to standard radiotherapy. We aimed (1) to develop and dosimetrically validate a proton pencil-beam scanning lattice radiotherapy (LRT) planning technique, (2) to compare against a photon VMAT LRT technique, and (3) to assess which clinical sites are feasible for treatment. Methods: 10 cases were selected, covering sites in the brain, neck, pelvis, abdomen and shoulder with gross tumor volumes greater than 100 cm3. LRT plans were developed for a Varian ProBeam system, aiming to deliver 20 Gy to the lattice vertices while minimizing dose to surrounding tissues. Plan-specific quality assurance (PSQA) was performed by independent Monte-Carlo calculation and physical dosimetric verification. End-to-end tests were performed using a CIRS head phantom containing EBT4 film. Plan quality was evaluated against VMAT LRT. Results: Clinically acceptable proton LRT plans were produced, delivering 16-20 Gy to the lattice vertices, a mean PTV dose of 2 Gy and satisfying organ-at-risk dose constraints. PSQA and end-to-end tests met clinical tolerances for non-LRT plans. For large target volumes, proton LRT produced lattices with a greater number of vertices than VMAT LRT. Conclusions: Proton LRT is technically viable using currently available delivery systems. Large tumors such as sarcoma are the most likely candidates for future clinical studies, but proton LRT is feasible for target volumes as small as 100 cm3. Advances in knowledge: The study demonstrates the feasibility of proton LRT for early phase clinical trials.
- Open Access
- 3 November 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111264
The concept of virtual clinical trials: A game changer in radiation oncology research?
- 3 November 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 214, 111264
Open AccessThe concept of virtual clinical trials: A game changer in radiation oncology research?
- Open Access
- 13 March 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 34, 100745
Cone-beam computed tomography reconstruction for a commercial proton beam therapy system
- 13 March 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 34, 100745
Open AccessCone-beam computed tomography reconstruction for a commercial proton beam therapy system
- Open Access
- 8 March 2024
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 30, 100241
“Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy
- 8 March 2024
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 30, 100241
Open Access“Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy
- Open Access
- 21 November 2022
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 38, 147-154
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
- 21 November 2022
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 38, 147-154
Open AccessTORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
- Open Access
Oxygen Depletion in Proton Spot Scanning: A Tool for Exploring the Conditions Needed for FLASH
FLASH radiotherapy is a rapidly developing field which promises improved normal tissue protection compared to conventional irradiation and no compromise on tumour control. The transient hypoxic state induced by the depletion of oxygen at high dose rates provides one possible explanation. However, studies have mostly focused on uniform fields of dose and there is a lack of investigation into the spatial and temporal variation of dose from proton pencil-beam scanning (PBS). A model of oxygen reaction and diffusion in tissue has been extended to simulate proton PBS delivery and its impact on oxygen levels. This provides a tool to predict oxygen effects from various PBS treatments, and explore potential delivery strategies. Here we present a number of case applications to demonstrate the use of this tool for FLASH-related investigations. We show that levels of oxygen depletion could vary significantly across a large parameter space for PBS treatments, and highlight the need for in silico models such as this to aid in the development and optimisation of FLASH radiotherapy.
Open AccessOxygen Depletion in Proton Spot Scanning: A Tool for Exploring the Conditions Needed for FLASH
FLASH radiotherapy is a rapidly developing field which promises improved normal tissue protection compared to conventional irradiation and no compromise on tumour control. The transient hypoxic state induced by the depletion of oxygen at high dose rates provides one possible explanation. However, studies have mostly focused on uniform fields of dose and there is a lack of investigation into the spatial and temporal variation of dose from proton pencil-beam scanning (PBS). A model of oxygen reaction and diffusion in tissue has been extended to simulate proton PBS delivery and its impact on oxygen levels. This provides a tool to predict oxygen effects from various PBS treatments, and explore potential delivery strategies. Here we present a number of case applications to demonstrate the use of this tool for FLASH-related investigations. We show that levels of oxygen depletion could vary significantly across a large parameter space for PBS treatments, and highlight the need for in silico models such as this to aid in the development and optimisation of FLASH radiotherapy.
- Open Access
- 25 February 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (5) , 055020
Determining the parameter space for effective oxygen depletion for FLASH radiation therapy
There has been a recent revival of interest in the FLASH effect, after experiments have shown normal tissue sparing capabilities of ultra-high-dose-rate radiation with no compromise on tumour growth restraint. A model has been developed to investigate the relative importance of a number of fundamental parameters considered to be involved in the oxygen depletion paradigm of induced radioresistance. An example eight-dimensional parameter space demonstrates the conditions under which radiation may induce sufficient depletion of oxygen for a diffusion-limited hypoxic cellular response. Initial results support experimental evidence that FLASH sparing is only achieved for dose rates on the order of tens of Gy s −1 or higher, for a sufficiently high dose, and only for tissue that is slightly hypoxic at the time of radiation. We show that the FLASH effect is the result of a number of biological, radiochemical and delivery parameters. Also, the threshold dose for a FLASH effect occurring would be more prominent when the parameterisation was optimised to produce the maximum effect. The model provides a framework for further FLASH-related investigation and experimental design. An understanding of the mechanistic interactions producing an optimised FLASH effect is essential for its translation into clinical practice.
- 25 February 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (5) , 055020
Open AccessDetermining the parameter space for effective oxygen depletion for FLASH radiation therapy
There has been a recent revival of interest in the FLASH effect, after experiments have shown normal tissue sparing capabilities of ultra-high-dose-rate radiation with no compromise on tumour growth restraint. A model has been developed to investigate the relative importance of a number of fundamental parameters considered to be involved in the oxygen depletion paradigm of induced radioresistance. An example eight-dimensional parameter space demonstrates the conditions under which radiation may induce sufficient depletion of oxygen for a diffusion-limited hypoxic cellular response. Initial results support experimental evidence that FLASH sparing is only achieved for dose rates on the order of tens of Gy s −1 or higher, for a sufficiently high dose, and only for tissue that is slightly hypoxic at the time of radiation. We show that the FLASH effect is the result of a number of biological, radiochemical and delivery parameters. Also, the threshold dose for a FLASH effect occurring would be more prominent when the parameterisation was optimised to produce the maximum effect. The model provides a framework for further FLASH-related investigation and experimental design. An understanding of the mechanistic interactions producing an optimised FLASH effect is essential for its translation into clinical practice.
- 1 July 2020
- Published by Elsevier in Clinical Oncology
- Vol. 32 (7) , 459-466
Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials
- 1 July 2020
- Published by Elsevier in Clinical Oncology
- Vol. 32 (7) , 459-466
Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials